COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION (AMR) WITH MIXED CELLULAR AND AMR IN REGARDS TO THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS
| dc.contributor.author | Ozdemir, B. Handan | |
| dc.contributor.author | Ayva, Sebnem | |
| dc.contributor.author | Terzi, Aysen | |
| dc.contributor.author | Sade, L. Elif | |
| dc.contributor.author | Basturk, Bilkay | |
| dc.contributor.author | Sezgin, Atilla | |
| dc.date.accessioned | 2020-10-20T11:16:46Z | |
| dc.date.available | 2020-10-20T11:16:46Z | |
| dc.date.issued | 2019 | |
| dc.identifier.endpage | 213 | en_US |
| dc.identifier.issn | 0934-0874 | en_US |
| dc.identifier.startpage | 213 | en_US |
| dc.identifier.uri | http://hdl.handle.net/11727/4945 | |
| dc.identifier.volume | 32 | en_US |
| dc.identifier.wos | 000491488703204 | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.journal | TRANSPLANT INTERNATIONAL | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION (AMR) WITH MIXED CELLULAR AND AMR IN REGARDS TO THE DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS | en_US |
| dc.type | conferenceObject | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: